Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics, 2012 Cancer Growth and Progression Series, Vol. 14
Coordonnateurs : Tao Jianguo, Sotomayor Eduardo
Preface.-1 B-Cell Growth, Differentiation and Malignancies .-2 Follicular Lymphoma: Recent advances.-3 Chronic Lymphocytic Leukemia: From Pathobiology to Targeted Therapy.-4 Genetic and Environmental Determinants in Multiple Myeloma: Implications for Therapy.-5 EBV-Positive Diffuse Large B-Cell Lymphoma of the Elderly.-6 HIV and Lymphoma.-7 Molecular Biology of Mantle Cell Lymphoma.-8 Pathogenesis of Non-Hodgkin Lymphoma Derived from Inflammatory, Autoimmune or Immunologic Disorders.-9 Pathogenesis of Non-Hodgkin Lymphoma Derived from Infection Diseases.-10 Hodgkin Lymphoma: From Molecular Pathogenesis to Targeted Therapy.-11 Myelodysplastic Syndromes.-12 Chronic Myeloproliferative Disorders: from Molecular Pathogenesis to Targeted Therapy.-13 Chronic Myeloid Leukemia.-14 Novel Targeted Therapeutics for Acute Myeloid Leukemia.-15 Novel Targeted Therapeutics for Peripheral T-Cell Lymphoma.-16 Large Granular Lymphocyte Leukemia – From Molecular Pathogenesis to Targeted Therapy.-17 Epigenetic Regulation and Therapy in Lymphoid Malignancies.-Index.
Date de parution : 11-2012
Ouvrage de 426 p.
15.5x23.5 cm
Thèmes de Hematologic Cancers: From Molecular Pathobiology to... :
Mots-clés :
Leukemia; Lymphoma; Molecular Pathogenesis; Targeted Therapy; Apoptosis